v3.26.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at the beginning at Jun. 30, 2024 $ 47,248 $ 1 $ 238,398 $ (190,259) $ (892)
Balance at the beginning (In shares) at Jun. 30, 2024   10,086,119      
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs of $2,252 28,208 $ 1 28,207    
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs of $2,252 (In Shares)   2,043,000      
Exercise of pre-funded warrants, Shares   2,374,583      
Exercise of Series 2 warrants 2,999   2,999    
Exercise of Series 2 warrants (In shares)   1,553,927      
Exercise of common warrants 39,278   39,278    
Exercise of common warrants (Shares)   10,192,840      
Share-based compensation 17,426   17,426    
Foreign currency translation gain (loss) 53       53
Net loss (37,917)     (37,917)  
Balance at end at Jun. 30, 2025 97,295 $ 2 326,308 (228,176) (839)
Balance at end (In shares) at Jun. 30, 2025   26,250,469      
Issuance of common stock sold for cash, net of offering costs of $6,266 98,230 $ 1 98,229    
Issuance of common stock sold for cash, net of offering costs of $6,266 (Shares)   7,740,370      
Exercise of pre-funded warrants, Shares   200,276      
Exercise of Series 2 warrants 123   123    
Exercise of Series 2 warrants (In shares)   63,792      
Exercise of common warrants 625   625    
Exercise of common warrants (Shares)   161,927      
Share-based compensation 26,410   26,410    
Foreign currency translation gain (loss) (124)       (124)
Net loss (45,546)     (45,546)  
Balance at end at Jun. 30, 2026 $ 177,013 $ 3 $ 451,695 $ (273,722) $ (963)
Balance at end (In shares) at Jun. 30, 2026   34,416,834